NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today priced its previously announced senior notes being issued to partially fund its $3.5 billion purchase of Phadia.
In total, the company is offering $2.1 billion in senior notes — $1 billion worth of 2.25 percent notes due 2016 at an issue price of 99.826 percent of the principal amount, and $1.1 billion of 3.6 percent notes due in 2021 at an issue price of 99.809 percent of the principal amount.
The issuance of the notes is expected to close on Aug. 16 and will pay interest on a semi-annual basis.
Ratings firm Fitch yesterday assigned an "A-" rating to the notes.